Related Experiment Video
Updated: Jun 18, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
Impact of Fractionation Regimen on Local Control Following Frameless Linear Accelerator-Based Image-Guided
Adam Beighley1, Yazeed Kesbeh1, Javad Rahimian1
1Department of Radiation Oncology, Southern California Permanente Medical Group, Los Angeles, California, USA.
World Neurosurgery
|July 28, 2024
Summary
Stereotactic radiosurgery (SRS) and fractionated radiotherapy (RT) offer durable local control for intracranial meningioma. Treatment outcomes were similar across different fractionation regimens, allowing tailored recommendations based on clinical factors.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Oncology
Background:
- Stereotactic radiosurgery (SRS) is a primary treatment for intracranial meningioma.
- Tumor size and critical structure proximity can limit SRS applicability.
- Fractionated radiotherapy (RT) offers an alternative for complex cases.
Purpose of the Study:
- To compare local control (LC) outcomes of three stereotactic techniques for benign intracranial meningioma.
- To evaluate the efficacy of SRS, fractionated SRS, and conventionally fractionated stereotactic radiotherapy (FSRT).
Main Methods:
- Retrospective review of 543 patients with 613 meningiomas treated between 2008-2021.
- Comparison of SRS (n=211), fractionated SRS (n=170), and FSRT (n=232).
- Analysis of definitive or postoperative treatment settings, including recurrent disease.
Main Results:
- Overall 5/10/14-year LC was 97.4%/86.8%/86.8%.
- No significant difference in LC was observed between SRS, fractionated SRS, and FSRT regimens.
- Factors associated with inferior LC included skull base location, tumor volume ≥5 cc, and recurrent disease.
Conclusions:
- Stereotactic radiotherapy provides durable long-term local control for intracranial meningioma.
- Fractionation regimen did not significantly impact LC outcomes.
- Treatment decisions can be guided by clinical factors without compromising efficacy.

